Viewing Study NCT07240194

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 1:40 AM

Ignite Modification Date: 2025-12-25 @ 11:56 PM

Study NCT ID: NCT07240194

Status: RECRUITING

Last Update Posted: 2025-11-20

First Post: 2025-09-25

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: The Efficacy and Safety of Glofitamab in Combination With PD-1 Antibody and Lenalidomide in Patients With Relapsed/Refractory Large B-cell Lymphoma (LBCL) With TP53 Aberrations: A Prospective, Multicenter, Phase II Clinical Study

Sponsor: The First Affiliated Hospital with Nanjing Medical University

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module